SXI Life Sciences
6.857,51
PKT
-11,95
PKT
-0,17
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.08.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.07.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.07.22 | Roche Neutral | Credit Suisse Group | |
| 25.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 22.07.22 | Roche Hold | Deutsche Bank AG | |
| 21.07.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.07.22 | Roche Neutral | UBS AG | |
| 21.07.22 | Roche Outperform | Bernstein Research | |
| 21.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 20.07.22 | Novartis Neutral | Credit Suisse Group | |
| 20.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.07.22 | Roche Hold | Deutsche Bank AG | |
| 20.07.22 | Novartis Sell | Deutsche Bank AG | |
| 19.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.07.22 | Novartis Neutral | UBS AG | |
| 19.07.22 | Novartis Buy | Jefferies & Company Inc. | |
| 18.07.22 | Novartis Underweight | Barclays Capital | |
| 18.07.22 | Roche Overweight | Barclays Capital | |
| 18.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 15.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 14.07.22 | Roche Hold | Deutsche Bank AG | |
| 13.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.07.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.07.22 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.07.22 | Roche Neutral | UBS AG | |
| 07.07.22 | Roche Hold | Jefferies & Company Inc. | |
| 05.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 01.07.22 | Novartis Neutral | UBS AG | |
| 30.06.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 29.06.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 29.06.22 | Novartis Sell | Deutsche Bank AG | |
| 22.06.22 | Novartis Neutral | UBS AG | |
| 22.06.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.06.22 | Novartis Sell | Deutsche Bank AG | |
| 16.06.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.06.22 | Roche Hold | Deutsche Bank AG | |
| 07.06.22 | Roche Neutral | JP Morgan Chase & Co. |